The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Check with a doctor before using these creams for itchy skin in winter. Itchy skin in winter is common, but people with dry ...

As the colder weather sets in, there are a number of health conditions that can be triggered or worsened by the winter months ...

As winter sets in, so does cold and flu season, but the colder temperatures can also exaggerate many existing health ...

Ad hoc announcement pursuant to Art. 53 LR Approximately 7% of people in the United States (U.S.) have atopic dermatitis - a common, chronic, and ...

Galderma anticipates nemolizumab to approach ?blockbuster' net sales run-rate by the end of 2027. to treat adults and children 12 years of age and older with moderate-to-severe eczema (atopic ...

Nemolizumab is a first-in-class monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31. 2 IL-31 is a neuroimmune cytokine that drives itch and is ...

A new study finds that that eczema can worsen when air quality drops from good to moderate levels on the Environmental ...

"Cod liver oil, in particular, is also rich in retinol, which is a type of vitamin A that is fat-soluble and an important ...

UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema: United Kingdom Thursday, December 12, 20 ...

Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...